Ensuring Patient Access to Critical Breakthrough Products

December 31, 2024

Advancing Access to Breakthrough Medical Devices: A 2025 Priority

This bipartisan legislation would enable millions of patients to receive quicker access to life- changing medical innovations. The legislation is designed to expedite the Medicare coverage determination process of breakthrough medical technologies for patients.


Although the House of Representatives generated some momentum on related legislation, H.R. 1691, a Senate companion bill, S. 5349, the “Ensuring Patient Access to Critical Breakthrough Products Act”, was introduced in late November 2024 for potential passage in the lame duck session.


S. 5349 would grant four years of national coverage to any FDA-authorized Breakthrough Device after CMS affirms its status and requires the Medicare agency to consider a permanent national coverage policy during that period.


MichBio, and its partners, AdvaMed and MDMA, as well as other medical device industry advocates pushed Congress to pass the “Ensuring Patient Access to Critical Breakthrough Products Act” this year as part of an end-of-year federal spending bill. Alas, it was not meant to be, as this bill, like many others, died an inglorious death. The legislation will be a high priority for 2025.

RECENT ARTICLES

March 28, 2025
Secure Your Spot at The MedTech Conference 2025 with MichBio!
March 28, 2025
Propelling Innovation in CNS Biotherapeutics
March 28, 2025
Dexter Biometry is a contract bioinformatics service, specializing in data analysis, data visualization dashboards and reports, pipeline automation and other digital services for biotech, pharma and academic science. Founded in 2024 to help scientists lacking adequate informatics staff quickly solve a wide variety of data problems, they have leveraged decades of scientific experience to help clients across the country and across scientific disciplines. They have provided cost-effective client solution at a variety of scales, from assistance with manuscript preparation all the way to cloud deployments of containerized pipelines. Early clients have primarily focused on genomics, proteomics and immune oncology, however Dexter Biometry is currently expanding their services into other fields such as virology and agricultural genomics. Built on client relationships in San Diego and Baltimore, Dexter Biometry is looking to build relationships with clients closer to their home in Dexter, MI, where remote services can be augmented with on-site help when needed. Visit their website to learn more: https://dexterbiometry.com/ 
Share by: